Trader Note — 11151 total
MRCY heads into mid-September with a sharp 7.4% single-day bounce to $87.01 obscuring a messier picture underneath: the CEO sold more than $13 million in open-market stock just weeks ago, shorts have been rebuilding…
MRK enters the week with its most defensive options positioning of the past year, even as the Street continues to raise targets — a split that puts the market and analysts squarely at odds. The options signal is the…
McDonald's has dropped 7% in a month and now faces its September 23 earnings print with the Street actively trimming expectations — a setup that puts execution squarely under the microscope. The positioning story is…
MarineMax heads into the final weeks of its fiscal year with a fresh activist on the register, a stock trading above the analyst consensus target, and a meaningful short interest base that has been quietly…
MGM Resorts International heads into the final stretch of September with a familiar tension: shorts are rebuilding, the Street is trimming targets, and the stock is down 11% over the past month — yet analysts still…
Lockheed Martin heads into the week of September 15 with a notable tension: the Street has turned more constructive just as the stock has shed more than 12% over the past month, leaving bulls and bears debating whether…
Bath & Body Works enters mid-September under pressure on multiple fronts — the stock has shed 11.5% in a week to $16.72, short sellers have rebuilt positions at a pace not seen in months, and the analyst community has…
Eli Lilly and Company heads into the back half of September with the short rebuild that dominated last week's note showing its first real signs of fatigue — yet the broader story remains intact. Short interest slipped…
Lexicon Pharmaceuticals enters the week with an unusual ownership story dominating the setup — a declared activist controlling nearly 40% of shares, a meaningful short position that has been quietly unwinding, and a…
LEN reported Q3 results on September 16, and the post-earnings picture looks largely consistent with what the bears anticipated: short interest has held near its monthly highs, a wave of analyst target cuts arrived in…
Landstar System heads into the final weeks of Q3 with short sellers quietly rebuilding positions into a stock that has lost nearly a tenth of its value over the past month. The most notable development this week is the…
Kimberly-Clark enters its October 20 earnings window under mounting pressure — short sellers are rebuilding positions, analysts are cutting targets, and options traders are the most defensively positioned they've been…
KB Home arrives at its September 22 earnings date carrying a notable tension: short sellers have been quietly adding exposure over the past week while analysts trim their targets ahead of the print. Short interest has…
Jones Lang LaSalle heads into its October 27 earnings date down 9% over the past month, yet the options market has just turned notably less defensive — a divergence worth watching. The most striking move this week is…
JPMorgan Chase heads into the final stretch before its October 13 Q3 results with one genuinely new signal this week: options traders have turned the most defensively positioned they've been in months, even as the…
Iron Mountain enters the back half of September nursing a 3.5% weekly loss and a sharper 13.4% slide over the past month, pushing the stock to $112.04 — well below where the Street thinks it should trade. The most…
IBM heads into October earnings week with an interesting split: the stock just posted its best weekly gain in months, yet short sellers are quietly adding exposure at the same time. The price action dominates the…
Intel heads into Q3 earnings season — now confirmed for October 22 — down 7% on the week, with analysts pulling in opposite directions and short sellers pressing a position that has grown 29% in a month. The analyst…
Nektar Therapeutics enters the back half of September in a bruising stretch, down nearly 12% on the week to $66.64, even as short sellers — who hold a structurally large stake — have been quietly trimming exposure…
Incyte Corporation heads into the final weeks before its October 27 earnings with a notable split: the analyst community has turned more constructive since July results, yet the stock has given back 2.1% this week and…
